ALKT
Alkami Technology, Inc.
ALKT has the edge over ASTS overall, supported by stronger fundamentals and lower modeled downside.
ASTS
AST SpaceMobile, Inc.
ASTS offers stronger modeled upside, but that advantage does not outweigh its weaker overall profile.
ALKT Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Under pressure | |
| Healthy | |
| Strong |
ALKT's revenue, cash flow and balance sheet are currently healthy, but its profitability is under pressure.
ASTS Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Weak | |
| Unavailable |
ASTS's revenue is currently healthy, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
ALKT PE Valuation
ALKT has no meaningful PE right now: it lost money over the past year.
ASTS PE Valuation
ASTS has no meaningful PE right now: it lost money over the past year.
ALKT Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Strong growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for ALKT, with profitability improving.
ASTS Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses growing | |
| Strong growth | |
| -- | |
| Limited | |
| Low |
Analysts expect ASTS's losses to grow, with revenue growing. However, they disagree widely on these estimates.
ALKT Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.03 | — |
| Q3 2026 | -$0.34 | +$0.08 |
| Q2 2026 | -$0.42 | -$0.05 |
| Q1 2026 | -$0.47 | -$0.10 |
| Q4 2025 | -$0.46 | -$0.05 |
| Q3 2025 | -$0.42 | +$0.06 |
| Q2 2025 | -$0.37 | +$0.18 |
| Q1 2025 | -$0.37 | +$0.24 |
| Q4 2024 | -$0.41 | +$0.26 |
ALKT has the edge over ASTS on earnings, with more consistent year-over-year improvement.
ASTS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$2.15 | -$0.91 |
| Q2 2026 | -$2.16 | -$0.27 |
| Q1 2026 | -$1.80 | +$0.19 |
| Q4 2025 | -$1.34 | +$0.61 |
| Q3 2025 | -$1.24 | +$0.88 |
| Q2 2025 | -$1.89 | -$0.64 |
| Q1 2025 | -$1.99 | -$1.01 |
| Q4 2022 | -$0.58 | -$0.21 |
ASTS is still losing money, but far less than before: $2.15 per share over the past year, against $5.76 at its worst in mid-2021.
ALKT Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $134.9M | +19% |
| Q2 2026 | $129.8M | +16% |
| Q1 2026 | $126.1M | +29% |
| Q4 2025 | $120.8M | +35% |
| Q3 2025 | $113M | +31% |
| Q2 2025 | $112.1M | +36% |
| Q1 2025 | $97.8M | +29% |
| Q4 2024 | $89.7M | +26% |
ALKT's revenue has grown year over year every quarter since early 2021: $135M last quarter, up 19% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -4.6% | +6.8 points |
| Q2 2026 | -5.9% | +8.2 points |
| Q1 2026 | -4.5% | +11 points |
| Q4 2025 | -7.9% | +1.8 points |
| Q3 2025 | -11% | +0.7 points |
| Q2 2025 | -14% | +1.9 points |
| Q1 2025 | -16% | +0.5 points |
| Q4 2024 | -9.6% | +8.7 points |
ALKT has the edge over ASTS on profitability, with a higher operating margin.
ASTS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $42.3M | +187% |
| Q2 2026 | $31.5M | +2627% |
| Q1 2026 | $14.7M | +1952% |
| Q4 2025 | $54.3M | +2731% |
| Q3 2025 | $14.7M | +1240% |
| Q2 2025 | $1.2M | +28% |
| Q1 2025 | $718K | +44% |
| Q3 2022 | $4.2M | +70% |
ASTS's revenue has grown year over year for 11 quarters in a row: $42M last quarter, up 187% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -415% | +694 points |
| Q2 2026 | -948% | +10744 points |
| Q1 2026 | -1686% | +7083 points |
| Q4 2025 | -175% | +2446 points |
| Q3 2025 | -1109% | +4850 points |
| Q2 2025 | -11692% | -4693 points |
| Q1 2025 | -8769% | +2331 points |
| Q4 2024 | -2621% | N/A |
ASTS's operating margin was −415% last quarter, up 694 points from the same quarter a year ago.
ALKT Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $21.4M | -30% |
| Q2 2026 | $21.6M | +2747% |
| Q1 2026 | -$5.2M | +$962K |
| Q4 2025 | $16.2M | +173% |
| Q3 2025 | $30.5M | +186% |
| Q2 2025 | $760K | +518% |
| Q1 2025 | -$6.1M | -1053% |
| Q4 2024 | $6M | +$11.5M |
ALKT has the edge over ASTS on cash generation, producing positive trailing cash flow while its opponent burns cash.
ASTS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$464.2M | -$161.4M |
| Q2 2026 | -$694.8M | -$341.1M |
| Q1 2026 | -$309.7M | -$160.7M |
| Q4 2025 | -$330.7M | -$220.3M |
| Q3 2025 | -$302.9M | -$239.1M |
| Q2 2025 | -$353.6M | -$315.3M |
| Q1 2025 | -$149M | -$61.3M |
| Q4 2024 | -$110.5M | -$63.2M |
ASTS has burned cash in almost every quarter: −$1.8B over the past year, against −$916M the year before.
ALKT Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.2% | -235K shares |
| 1 year | +2.2% | +2.3M shares |
| 3 years | +13% | +12M shares |
| 5 years | +42% | +31.8M shares |
| Available history | +28% | +23.5M shares |
ALKT has the edge over ASTS on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $10M |
| Q4 2022 | — |
| Q3 2022 | — |
| Q2 2022 | — |
| Q1 2022 | — |
| Q4 2021 | — |
| Q3 2021 | — |
| Q2 2021 | $3,000 |
ASTS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.4% | +1.1M shares |
| 1 year | +10% | +27.3M shares |
| 3 years | +235% | +211M shares |
| 5 years | +480% | +248M shares |
| Available history | +944% | +271M shares |
ASTS has 300M diluted shares, up 10% from a year ago.
| Quarter | Spent |
|---|---|
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
| Q2 2024 | — |
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
| Q2 2023 | — |
ALKT Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -14.7x | Net Cash |
ALKT has more cash than debt.
ASTS Net Leverage
ASTS's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
ALKT Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 42.4 | Neutral |
| Stochastic | 12.8 | Oversold |
ALKT's weekly RSI is 42 (neutral) and its Stochastic is 13 (oversold).
ASTS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 34.1 | Neutral |
| Stochastic | 11.9 | Oversold |
ASTS's weekly RSI is 34 (neutral) and its Stochastic is 12 (oversold).
ALKT PE vs Technology Sector
ALKT has no meaningful PE right now: it lost money over the past year.
ASTS PE vs Technology Sector
ASTS has no meaningful PE right now: it lost money over the past year.
ALKT Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $13.9 | 0% above |
| 20 week MA | $17.1 | 18% below |
| 50 week MA | $17.7 | 21% below |
| 100 week MA | $22.6 | 38% below |
| 200 week MA | $22.9 | 39% below |
ALKT is in a downtrend: it's below all five of its weekly moving averages, and 39% below its 200-week average.
ASTS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $44.9 | 23% below |
| 20 week MA | $57.1 | 40% below |
| 50 week MA | $75.5 | 54% below |
| 100 week MA | $57.8 | 40% below |
| 200 week MA | $33.6 | 2.8% above |
ASTS has fallen below most of its moving averages, though it's still 2.8% above its 200-week average.
ALKT Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $42.1 | $19.7 | -53% |
| 2022 | $19.7 | $13.6 | -31% |
| 2023 | $13.6 | $24.3 | +78% |
| 2024 | $24.3 | $38.5 | +59% |
| 2025 | $38.5 | $23.1 | -40% |
| 2026 YTD | $23.1 | $13.9 | -40% |
ALKT has the edge over ASTS on returns for 2026, with the stronger performance.
ASTS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.87 | $13.4 | +36% |
| 2021 | $13.4 | $8.71 | -35% |
| 2022 | $8.71 | $3.97 | -54% |
| 2023 | $3.97 | $6.03 | +52% |
| 2024 | $6.03 | $22.9 | +280% |
| 2025 | $22.9 | $72.0 | +214% |
| 2026 YTD | $72.0 | $34.5 | -52% |
ASTS's yearly returns have swung widely, from +280% in 2024 to −54% in 2022. It's down 52% so far in 2026.